Intercept Pharmaceuticals Inc Bennfentes tulajdonlás
Mi az Intercept Pharmaceuticals Inc Bennfentes tulajdonlás?
A Bennfentes tulajdonlás az Intercept Pharmaceuticals Inc - 4.50%
Mi a Bennfentes tulajdonlás meghatározása?
A bennfentes tulajdonjog kiszámítása a bennfentesek tulajdonában lévő részvények (részvényesek, akik a vállalat több mint 5% -át, vagy a vállalat tisztségviselőjét vagy igazgatóját birtokolják) teljes létszámával, osztva a teljes részvénykivonással.
A high value of insider ownership means that those working for the company have a large stake in the success of the company. This is sometimes seen as a sign that those running the company will work hard to ensure its success or believe the company's stock price will rise.
A change in insider ownership may come from exercise of option, stock grant and buying or selling of company shares. A purchase of company share signifies a confidence in the company's future performance by people who know the company best. Therefore, Net Insider buying is also an important indicator for investors.
Bennfentes tulajdonlás a Health Care szektor a NASDAQ-on cégekben a Intercept Pharmaceuticals Inc -hoz képest
Mit csinál Intercept Pharmaceuticals Inc?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
bennfentes tulajdonlás -hoz hasonló cégek Intercept Pharmaceuticals Inc
- ATTRAQT plc nak Bennfentes tulajdonlás 4.50% van
- Colony Capital nak Bennfentes tulajdonlás 4.50% van
- Deutsche Pfandbriefbank AG nak Bennfentes tulajdonlás 4.50% van
- BGSF Inc nak Bennfentes tulajdonlás 4.50% van
- Macquarie nak Bennfentes tulajdonlás 4.50% van
- Stepan Co nak Bennfentes tulajdonlás 4.50% van
- Intercept Pharmaceuticals Inc nak Bennfentes tulajdonlás 4.50% van
- Stoneridge nak Bennfentes tulajdonlás 4.51% van
- RigNet Inc nak Bennfentes tulajdonlás 4.51% van
- Marin Software Inc nak Bennfentes tulajdonlás 4.51% van
- Plus500 nak Bennfentes tulajdonlás 4.51% van
- Detection Technology Oyj nak Bennfentes tulajdonlás 4.51% van
- Banimmo SA nak Bennfentes tulajdonlás 4.51% van